Work

The ED90 of Liposomal Bupivacaine for Motor-Sparing After Interscalene Brachial Plexus Block: A Dose-Finding Study

Year: 2026
Type: article
Study design: Clinical Trial
Abstract: Purpose: In adult arthroscopic rotator cuff repair, interscalene brachial plexus block using liposomal bupivacaine has been proven to effectively provide analgesic effects. However, concerns about motor-blocking may restrict its widespread clinical application. This study aimed to determine the 90% minimum effective dose (ED90) of liposomal bupivacaine for successful sensory blockade with motor-sparing following ultrasound-guided interscalene brachial plexus block. Patients and Methods: A total of 55 patients undergoing arthroscopic rotator cuff repair received an ultrasound-guided interscalene block using liposomal bupivacaine. The study employed an up-and-down sequential method with a biased-coin design. The primary outcome was the ED90 of liposomal bupivacaine in middle-aged patients undergoing motor-sparing (sensory score of 1 or 2 and a motor score of > 2 during 3– 72 hours after surgery) ultrasound-guided interscalene brachial plexus block. Secondary outcomes included Numerical Rating Scale (NRS) and numbness scores; as well as the percentage change in diaphragmatic excursion and pulse oxygen saturation (SpO 2 ) from baseline to the Post-Anesthesia Care Unit (PACU). Results: In total, 53 patients completed the study. The estimated ED90 of liposomal bupivacaine was 46.55 mg [90% confidence interval (CI), 39.36– 48.41]. There was no significant difference observed in diaphragmatic excursion ( P =0.164) and SpO 2 ( P =0.820) in the PACU between the motor-sparing group and motor-blocking group. There was no severe pain (Scores 7– 10) on movement or at rest and no severe numbness (Scores=3) during the 72 hours after blocking. There were no reports of other complications, except for two female patients who developed nausea and vomiting after completion of the blocks. Conclusion: Motor-sparing ultrasound-guided interscalene brachial plexus block using liposome bupivacaine with a dose of 46.55 mg enables successful sensory blocks in 90% of middle-aged adults after excluding cases with failed sensory blockade. Keywords: liposomal bupivacaine, interscalene brachial plexus block, motor-sparing, ED90
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W7203755874
FWCI:
Cites: 32
Cited by:
Related to: 10